HomeALZCUR • STO
add
AlzeCure Pharma AB
Previous close
kr 2.50
Day range
kr 2.34 - kr 2.48
Year range
kr 0.81 - kr 3.86
Market cap
215.44M SEK
Avg Volume
75.84K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.24M | 2.40% |
Net income | -10.11M | -3.10% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.20M | -3.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.82M | 9.36% |
Total assets | 24.72M | 8.95% |
Total liabilities | 8.64M | -0.88% |
Total equity | 16.08M | — |
Shares outstanding | 88.30M | — |
Price to book | 13.89 | — |
Return on assets | -86.54% | — |
Return on capital | -121.13% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.11M | -3.10% |
Cash from operations | -10.68M | -6.12% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -10.68M | -6.12% |
Free cash flow | -6.97M | -7.09% |
About
Founded
2012
Website
Employees
11
